Integrating Biomarkers into Bladder Cancer Clinical Trials (2024)

Linthicum, MD US
March 15, 2024 to March 16, 2024

Johns Hopkins Greenberg Bladder Cancer Institute and American Urological Association Translational Research Collaboration

Integrating Biomarkers into Bladder Cancer Clinical Trials (2024) will be held in-person, March 15-16, 2024 at AUA Headquarters in Linthicum, MD.

The seventh annual translational research meeting co-sponsored by the American Urological Association and the Johns Hopkins Greenberg Bladder Cancer Institute will be a two-day, in-person symposium focused on the “Integrating Biomarkers into Bladder Cancer Clinical Trials”.

Note the deadline for registration is Friday, March 15, 2024 at 2:OO pm EST. 

PROGRAM PLANNING COMMITTEE

  • David McConkey, PhD (Chair) - Johns Hopkins University Greenberg Bladder Cancer Institute
  • Jonathan Dudley, MD - Johns Hopkins University
  • Bishoy Faltas, MD - Weill Cornell
  • Matthew Galsky, MD - Mount Sinai
  • Roger Li, MD - Moffitt Cancer Center
  • Joshua Meeks, MD, PhD - Northwestern Medicine
  • Kent Mouw, MD, PhD - Dana-Farber Cancer Institute, Harvard University

COURSE REGISTRATION FEES

Membership CategoryPrice

MD/PhD Member

$260

MD/PhD Non-Member

$320

Member Medical Student, Resident, Fellow

$160

Non-Member Medical Student, Resident, Fellow

$175

Employees of Industry

$520

Invited Faculty/Speakers

$0

Target Audience

  • Urologists
  • Research scientists
  • Clinical and research faculty
  • Clinical and postdoctoral fellows
  • Residents
  • Medical and graduate students
  • Medical professionals employed by industry

Learning Objectives

  1. Describe the major types of biomarkers in development for urothelial cancer.
  2. Explain the clinical needs that are being addressed by plasma and urine “liquid biopsies”.
  3. Discuss the “state of the science” in the development of microbiome biomarkers.
  4. Describe the use of “AI path” to predict clinical outcomes.
Course summary
Course opens: 
01/17/2024
Course expires: 
03/16/2027
Event starts: 
03/15/2024 - 2:00pm EDT
Event ends: 
03/16/2024 - 3:45pm EDT
List Price:
$260.00
Rating: 
0

*agenda updates will be posted as they become available.
All times are listed in EST.

2024 AUA-JHU GBCI Bladder Cancer Research Symposium
Integrating Biomarkers into Bladder Cancer Clinical Trials
Friday, March 15 - Saturday, March 16, 2024
AUA Headquarters, Linthicum, Maryland, USA

 

Friday, March 15, 2024

Time

Session

Speaker(s)

2-2:45 pm

Conference registration and reception

2:45-3 pm

Chair Introduction

David McConkey, PhD

JHU

3-4 pm

BCAN-led patient panel discussion

 

How would you feel about enrolling in a clinical trial in which your therapy would be determined based on a biomarker?

Moderator

Stephanie Chisolm, PhD

BCAN

 

Panelists

  1. Fran Curtis, Patient Speaker

Doug MacLean, Patient Speaker

4-4:15 pm

Break

4:15-6:15 pm

Session 1: Tissue-based Genomic Biomarkers

4:15-4:20 pm

Session 1 Introduction

Moderator

Kent Mouw, MD, PhD, Dana-Farber Cancer Institute, Harvard University

4:20-4:40 pm

Interrogating the Role of Epigenetic Factors as Biomarkers of Response to Immune Checkpoint Therapy

Sangeeta Goswami, MD, PhD

MD Anderson

4:40-5:00 pm

Tumor Cell Intrinsic Drivers of Densitivity to

Chemotherapy and Radiation

Kent Mouw, MD, PhD

Dana-Farber Cancer Institute, Harvard University

5:00-5:20 pm

Biomarkers in TIME and space: is humoral immunity a missing link to prediction of response to BCG?

Madhuri Koti, DVM, MVSc., PhD

Queens University

5:20-5:40 pm

Comprehensive Evaluation of Molecular Correlates for Chemotherapeutic Response

Woonyoung Choi, PhD, MS

JHU

5:40-6:15 pm

Session 1 Panel Q&A

Moderator

Kent Mouw, MD, PhD, Dana-Farber Cancer Institute, Harvard University

 

Panelists

  1. Sangeeta Goswami, MD, PhD, MD Anderson
  2. Madhuri Koti, DVM, MVSc., PhD, Queens University
  3. Woonyoung Choi, PhD, MS, JHU

6:15-7 pm

Reception with Museum Tour

Tupper Stevens, MLS

American Urological Association (AUA)

7-9:30 pm

Conference dinner

    

Saturday, March 16, 2024

Time

Session

Speaker

8:00 - 8:30 am

Networking breakfast

8:30 – 11:00 am

Session 2: Liquid Biopsies: Urine & Plasma

8:30 - 8:35 am

Session 2 Introduction

Moderators

  1. Jonathan Dudley, MD, JHU
  2. Matt Galsky, MD, Mount Sinai

8:35 - 9:00 am

Detection and surveillance of bladder cancer using urine tumor DNA

Jonathan Dudley, MD

JHU

9:00 - 9:25 am

Integrating Liquid Biopsies in Clinical Trials – Where we stand and what’s on the horizon?

Roger Li, MD

Moffitt Cancer Center

9:25 - 9:50 am

Urinary tumor DNA for simultaneous minimal residual disease detection and comprehensive genomic profiling of UC

Trevor Levin, PhD

Convergent Genomics

9:50 - 10:15 am

Advances in Molecular Diagnostics for Oncology: Signatera MRD Testing in Bladder Cancer

Minetta Liu, MD

Natera

10:15 - 10:40 am

Clinical development of ctDNA-guided therapeutic approaches in urothelial cancer

Matt Galsky, MD

Mount Sinai

10:40 – 11:00 am

Session 2 Panel Q&A

Moderators

  1. Jonathan Dudley, MD, JHU
  2. Matt Galsky, MD, Mount Sinai

 

Panelists

  1. Roger Li, MD, Moffitt Cancer Center
  2. Trevor Levin, PhD, Convergent Genomics
  3. Minetta Liu, MD, Natera

11:00 - 11:15 am

Break

11:15 am –

12:15 pm

Microbiome Panel Discussion:

 

Do we have robust biomarkers?

 

Moderator

David McConkey, PhD, JHU

 

Panelists

  1. Laura Bukavina, MD, Case-Western
  2. Cynthia L. Sears, MD, JHU
  3. Armine Smith, MD, JHU

12:15 - 1:45 pm

Networking Lunch

1:45 - 3:45 pm

Session 3: AI/Path

Moderators

  1. Bishoy Faltas, MD, Weill Cornell
  2. Seth Lerner, MD, Baylor College of Medicine

1:45 - 2:15 pm

Predicting Clinical Outcomes in the S1314-COXEN Trial Using a Multimodal Deep Learning Model Integrating Histopathology, Cell Types, and Gene Expression

Bishoy Faltas, MD

Weill Cornell

2:15 - 2:45 pm

Predictive models of response to neoadjuvant chemotherapy in muscle-invasive bladder cancer using nuclear morphology and tissue architecture

Alexander Spyridon Baras, MD, PhD

JHU

2:45 - 3:15 pm

Pathology-Based Deep Learning Tools to Personalize Treatment Decisions

Erin Stewart, PhD

ArteraAI

3:15 - 3:45 pm

Session 3 Panel Q&A

Moderators

  1. Bishoy Faltas, MD, Weill Cornell
  2. Seth Lerner, MD, Baylor College of Medicine

 

Panelists

  1. Alexander Spyridon Baras, MD, PhD, JHU
  2. Erin Stewart, PhD, ArteraAI

3:45 pm

Conference wrap-up and adjourn

American Urological Association
1000 Corporate Boulevard
Linthicum, MD 21090
United States
+1 (410) 689-3700

Travel

For travel information, please contact Pia Crone, pcrone@auanet.org

Hotel Overview:
Hilton Garden Inn BWI Airport
1516 Aero Drive
Linthicum, MD 20190
Check in: 3:00 PM
Check out: 12:00 PM
Call in:  (410) 691-0500 / Room block name: AUA / JHU Joint Meeting
Hotel: Please use the link below to book through AUA’s corporate rate:
https://www.hilton.com/en/book/reservation/rooms/?ctyhocn=BWIAHGI&arrivalDate=2024-01-17&departureDate=2024-01-18&room1NumAdults=1

Shuttle Service: Complimentary shuttle service to and from Baltimore Washington International (BWI) Airport is provided to guests by the hotel. To coordinate pick-up from BWI, please call the main desk to request transportation AFTER you have picked up your luggage.

Price

List Price:
$260.00
Please login or register to take this course.

Note the deadline for registration is Friday, March 15, 2024 at 2:OO pm EST. 

Registration Fees

Membership CategoryPrice

MD/PhD Member

$260

MD/PhD Non-Member

$320

Member Medical Student, Resident, Fellow

$160

Non-Member Medical Student, Resident, Fellow

$175

Employees of Industry

$520

Invited Faculty/Speakers

$0